Bendamustine for Relapsed and Refractory Hodgkin Lymphomas: Four Cases and a Review of the Literature

Journal Title: International Blood Research & Reviews - Year 2014, Vol 2, Issue 4

Abstract

Aims: The management of relapsed/refractory Hodgkin lymphoma is challenging and new choices are needed. Brentuximab vedotin and bendamustine are two effective drugs in these cases. The aim of this study is to present the response to bendamustine after brentuximab failure. Study Design: Retrospective study evaluating the response to bendamustine in four cases with relapsed or refractory Hodgkin lymphoma. Place and Duration of Study: Cukurova University Faculty of Medicine Department of Oncology, between 2012 and 2014. Methodology: Clinical and metabolic responses to bendamustine in four cases with relapsed refractory Hodgkin lymphoma were evaluated. Informed consent was obtained from the patients. Bendamustine was used in four cases with very refractory Hodgkin lymphoma after Brentuximab failure. The dosage was 120 mg/M2 for two consecutive days in 4 weeks, without growth factor support. Results: Four cases with relapsed or refractory Hodgkin lymphoma were treated with bendamustine after brentuximab vedotin failure. Complete metabolic response was documented in two cases,one case did not respond and only short duration of response was determined in one case. Conclusion: Bendamustine is an effective and cost-effective choice in cases with relapsed/refractory Hodgkin lymphoma after brentuximab vedotin failure. However response is of short duration and definitive treatment must be performed as soon as possible.

Authors and Affiliations

Semra Paydas

Keywords

Related Articles

Blood Group Phenotype Frequencies in Blood Donors in the Northeast of Democratic Republic of Congo

Background and Aims: To know blood group antigen frequencies in a population has various benefits as the assessing risk of alloimmunization, the providing antigen-negative compatible blood to patients with multiples anti...

Iron Status and Red Cell Parameters in Pregnant and Non-pregnant Adolescents in Côte d’Ivoire (West Africa)

Aims: The objective of this study was to evaluate iron metabolism and compare iron stores between pregnant and non-pregnant adolescents in Côte d’Ivoire. Place and Duration of Study: The study was undertaken with 187 vo...

Assessment of Some Fibrinolytic Parameters during Pregnancy in Northern Nigeria

Aim: The study was undertaken to assess the fibrinolytic activity during pregnancy and to determine the effects of maternal age, gestation period and parity on fibrinolytic parameters in Northern Nigeria. Materials and M...

Transfusion Transmissible Infections among Blood Donors at the Blood Bank of Medical College of Gwalior: A 5 Year Study

Introduction: Transfusion Transmitted Infections (TTIs) are a major problem associated with blood transfusion. Accurate estimates of risk of TTIs are essential for monitoring the safety of blood supply and evaluating the...

Haematological Parameters of Adult and Paediatric Subjects with Sickle Cell Disease in Steady State, in Benin City, Nigeria

Background: Sickle cell disease (SCD) remains a major health burden in Sub-Saharan Africa and the management requires regular monitoring of the patients. The monitoring includes routine assessment of haematological param...

Download PDF file
  • EP ID EP242534
  • DOI 10.9734/IBRR/2014/8834
  • Views 85
  • Downloads 0

How To Cite

Semra Paydas (2014). Bendamustine for Relapsed and Refractory Hodgkin Lymphomas: Four Cases and a Review of the Literature. International Blood Research & Reviews, 2(4), 178-186. https://europub.co.uk/articles/-A-242534